» Articles » PMID: 28279988

Entorhinal Cortex: Antemortem Cortical Thickness and Postmortem Neurofibrillary Tangles and Amyloid Pathology

Overview
Specialty Neurology
Date 2017 Mar 11
PMID 28279988
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: The entorhinal cortex, a critical gateway between the neocortex and hippocampus, is one of the earliest regions affected by Alzheimer disease-associated neurofibrillary tangle pathology. Although our prior work has automatically delineated an MR imaging-based measure of the entorhinal cortex, whether antemortem entorhinal cortex thickness is associated with postmortem tangle burden within the entorhinal cortex is still unknown. Our objective was to evaluate the relationship between antemortem MRI measures of entorhinal cortex thickness and postmortem neuropathological measures.

Materials And Methods: We evaluated 50 participants from the Rush Memory and Aging Project with antemortem structural T1-weighted MR imaging and postmortem neuropathologic assessments. Here, we focused on thickness within the entorhinal cortex as anatomically defined by our previously developed MR imaging parcellation system (Desikan-Killiany Atlas in FreeSurfer). Using linear regression, we evaluated the association between entorhinal cortex thickness and tangles and amyloid-β load within the entorhinal cortex and medial temporal and neocortical regions.

Results: We found a significant relationship between antemortem entorhinal cortex thickness and entorhinal cortex ( = .006) and medial temporal lobe tangles ( = .002); we found no relationship between entorhinal cortex thickness and entorhinal cortex ( = .09) and medial temporal lobe amyloid-β ( = .09). We also found a significant association between entorhinal cortex thickness and cortical tangles ( = .003) and amyloid-β ( = .01). We found no relationship between parahippocampal gyrus thickness and entorhinal cortex ( = .31) and medial temporal lobe tangles ( = .051).

Conclusions: Our findings indicate that entorhinal cortex-associated in vivo cortical thinning may represent a marker of postmortem medial temporal and neocortical Alzheimer disease pathology.

Citing Articles

Role of tau versus TDP-43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease.

Wisse L, Wuestefeld A, Murray M, Jagust W, La Joie R Alzheimers Dement. 2025; 21(2):e14582.

PMID: 39985478 PMC: 11846482. DOI: 10.1002/alz.14582.


Association of quantitative histopathology measurements with antemortem medial temporal lobe cortical thickness in the Alzheimer's disease continuum.

Denning A, Ittyerah R, Levorse L, Sadeghpour N, Athalye C, Chung E Acta Neuropathol. 2024; 148(1):37.

PMID: 39227502 PMC: 11371872. DOI: 10.1007/s00401-024-02789-9.


Entorhinal vessel density correlates with phosphorylated tau and TDP-43 pathology.

Llamas Rodriguez J, van der Kouwe A, Oltmer J, Rosenblum E, Mercaldo N, Fischl B Alzheimers Dement. 2024; 20(7):4649-4662.

PMID: 38877668 PMC: 11247684. DOI: 10.1002/alz.13896.


Postmortem imaging reveals patterns of medial temporal lobe vulnerability to tau pathology in Alzheimer's disease.

Ravikumar S, Denning A, Lim S, Chung E, Sadeghpour N, Ittyerah R Nat Commun. 2024; 15(1):4803.

PMID: 38839876 PMC: 11153494. DOI: 10.1038/s41467-024-49205-0.


Alterations of gut microbiota are associated with brain structural changes in the spectrum of Alzheimer's disease: the SILCODE study in Hainan cohort.

He B, Sheng C, Yu X, Zhang L, Chen F, Han Y Front Aging Neurosci. 2023; 15:1216509.

PMID: 37520126 PMC: 10375500. DOI: 10.3389/fnagi.2023.1216509.


References
1.
Bennett D, Wilson R, Arvanitakis Z, Boyle P, de Toledo-Morrell L, Schneider J . Selected findings from the Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis. 2012; 33 Suppl 1:S397-403. PMC: 3434299. DOI: 10.3233/JAD-2012-129007. View

2.
Squire L . The medial temporal lobe memory system. Science. 1991; 253(5026):1380-6. DOI: 10.1126/science.1896849. View

3.
Killiany R, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F . Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol. 2000; 47(4):430-9. View

4.
Holtzman D, Carrillo M, Hendrix J, Bain L, Catafau A, Gault L . Tau: From research to clinical development. Alzheimers Dement. 2016; 12(10):1033-1039. DOI: 10.1016/j.jalz.2016.03.018. View

5.
Schneider J, Arvanitakis Z, Bang W, Bennett D . Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007; 69(24):2197-204. DOI: 10.1212/01.wnl.0000271090.28148.24. View